Iżrael - Ebrajk - Ministry of Health

eli lilly israel ltd, israel - teriparatide - תמיסה להזרקה - teriparatide 250 mcg/ml - teriparatide - teriparatide - treatment of postmenopausal women with osteoporosis at high risk for fracture:forteo is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. in postmenopausal women with osteoporosis, forteo increases bmd reduces the risk of vertebral and nonvertebral fractures . increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture :forteo is indicated to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy . treatment of men and women with glucocorticoid-induced osteoporosis at high risk for fracture:forteo is indicated for the treatment of men and women with osteopo

Iżrael - Ebrajk - Ministry of Health

abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 20 mg/ml - ibuprofen

Iżrael - Ebrajk - Ministry of Health

padagis israel agencies ltd, israel - vinorelbine as tartrate - קפסולות - vinorelbine as tartrate 20 mg - vinorelbine - vinorelbine - for the treatment of non small cell lung cancer. for the treatment of advanced breast cancer.

Iżrael - Ebrajk - Ministry of Health

padagis israel agencies ltd, israel - labetalol hydrochloride - טבליה - labetalol hydrochloride 100 mg - labetalol - labetalol - treatment of all grades of hypertension (mild, moderate and severe) when oral antihypertensive therapy is desirable.

Iżrael - Ebrajk - Ministry of Health

rafa laboratories ltd - phenoxybenzamine hydrochloride - קפסולות - phenoxybenzamine hydrochloride 10 mg - phenoxybenzamine - phenoxybenzamine - pheochromocytoma, benign prostatic hypertrophy.

Iżrael - Ebrajk - Ministry of Health

מסטמן מדיקל - רופא - the devices are intended for use by anaesthesiologists in order to create and maintain a patent airway during anaesthesia. the devices come in 7 sizes to suit all patients in which use of a laryngeal airway is indicated. the single-use device is marketed under the trade name ‘lapremiere plus’ and is supplied sterile. the reusable device is marketed under the trade name ‘laencore plus’ and is supplied non-sterile for reprocessing and sterilization by the user. these devices are accompanied by accessories to aid placement and fixation.

Iżrael - Ebrajk - Ministry of Health

מדוגר מכשור רפואי בע"מ - רופא - baylis pain management generator is indicated for use to create lesions during neurological lesion procedures, and for the coagulation and decompression of disc material to treat symptomatic patients with contained herniated discs.

Iżrael - Ebrajk - Ministry of Health

אבוט מעבדות רפואיות בע"מ באמצעות פרומדיקו בע"מ - אחות - enteral tube feeding is a method of providing nutrition to patients whose nutrition needs cannot be met by oral intake alone, for variety of clinical reasons. enteral feeding may be indicated for patients: who have difficulty chewing or swallowing, e.g. sroke, post-operative patients; with loss appetite due to chronic illness, e.g. cancer, hiv; with increased nutritional needs, e.g. wound healing, trauma/injury; with gastrointestinal disease, e.g. cancers of gi tract.

Iżrael - Ebrajk - Ministry of Health

זהר קוסמטיקס (מ.עו.פ) בעמ - מי פה

Iżrael - Ebrajk - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.